Abstract
As medical professionals with long-standing experience in sports physiology and sports medicine in both the academic and sports world, we would like to comment on the recent manuscript by Heuberger et al. 1 regarding the lack of evidence for the efficacy and the negative risk–benefit of erythropoietin (EPO) use in cycling. Indeed, it has been a moving sports summer, with the confession by dozens of professional cyclists of the use of, among other substances, erythropoietin, with the public confession of seven times Tour de France winner Lance Armstrong as the anticlimax. Erythropoietin use was like taking cups of coffee in the cycling world according to the following quotation: ‘Hey Dude, you got any Poe I can borrow? Lance pointed casually to the fridge. I opened it and there, on the door, next to a carton of milk, was a carton of EPO, each stoppered vial standing upright, little soldiers in their cardboard cells.’ 2.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
